Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

PreOmics

Explore full profile

Develops and provides innovative tools for customers around the world for mass spectrometry (MS)-based proteomics using cutting-edge technologies to support researchers in their protein analysis needs

Planegg, GermanyFounded 2016Biotech & Life Sciences
Valuation $50–100M Last recorded · 2022
Revenue $1–10M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for PreOmics and the history behind them.

About PreOmics

PreOmics is a cutting-edge startup specializing in the preparation of peptide and protein samples for Liquid Chromatography-Mass Spectrometry (LC-MS) analysis. The company operates in the proteomics market, which involves the large-scale study of proteins, particularly their structures and functions. PreOmics provides innovative and efficient solutions for researchers and scientists, enabling them to prepare samples quickly and reliably.

The company's primary clients include academic institutions, pharmaceutical companies, and biotechnology firms. These clients use PreOmics' products for various applications such as research and discovery, characterization of biopharmaceuticals, bioanalysis, and targeted analysis. Notable clients include prestigious institutions like Harvard Medical School and UCSF, which rely on PreOmics' technology to stabilize technical variations and focus on biological research.

PreOmics' business model revolves around selling specialized kits and automated systems for sample preparation. Their product lineup includes the iST kit for protein and peptide preparation, the iST NHS kit for chemical labeling, the PHOENIX kit for peptide cleanup, and the PreON system for fully automated sample preparation. These products are designed to streamline the workflow, reduce preparation time, and increase the reliability of results.

The company generates revenue by selling these kits and systems directly to its clients. Additionally, PreOmics offers consultation services to help researchers address unique biological questions and concerns, further enhancing the value of their products.

In summary, PreOmics is revolutionizing the proteomics field with its innovative sample preparation solutions, catering to a diverse range of clients in academia and industry. By providing quick, reliable, and automated workflows, the company helps researchers achieve greater depth in their proteome analysis.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2016
Headquarters
Planegg, Germany
Employees
54
Open positions
None listed
Dealroom signal
62.2/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotech & Life Sciences, Biotechnology, Microfluidics, Research and Development, Microbiology, Spinout, Mass Spectrometry, Headstart (EIT Health)
Technology
Hardware, Deep Tech
Business model
Manufacturing
Client focus
b2b

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Jan 2022 $15M $59M Bruker ↗
SERIES A✓Equity / VC Dec 2018 $3.6M $15M Think.Health · Business Angels Switzerland · HTGF ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

PreOmics website traffic

Latest recorded traffic for PreOmics is 13K monthly website visits, up 18.2% over the last three months. PreOmics's team declined 12.9% over the past year.

Latest monthly visits13K 3-month web change+18.2% 1-year team growth-12.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • Think.Health
  • Business Angels Switzerland
  • HTGF
  • Bruker

Other known investors6 additional known investors

  • EIT Health
  • Max Planck Innovation
  • Max Planck Institute for Biological Intelligence
  • Max Planck Institute of Biochemistry
  • Max Planck Society
  • LMU Entrepreneurship Center
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇩🇪 Germany84.1%
🇺🇸 United States11.4%
🇫🇷 France2.3%
🇬🇧 United Kingdom2.3%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about PreOmics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See PreOmics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.